Zetia Price Fixing Case Filed
June 29, 2018. Hartley LLP filed a class action complaint against Merck and Glenmark for engaging in anticompetitive activity surrounding the cholesterol drug, Zetia (ezetimibe). The complaint alleges that the drug’s brand manufacturer, Merck, entered into an unlawful reverse payment agreement with Glenmark, the generic drug manufacturer, to stay out of the Zetia market for [...]